Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

857 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.
Tamai H, Shingaki N, Shiraki T, Tukuda H, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Tamai H, et al. Among authors: inoue i. Hepatol Res. 2011 Dec;41(12):1137-44. doi: 10.1111/j.1872-034X.2011.00879.x. Epub 2011 Sep 26. Hepatol Res. 2011. PMID: 21951330
Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks.
Wada Y, Tamai H, Uno A, Kawashima A, Shingaki N, Mori Y, Moribata K, Miyata K, Higashi K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. Wada Y, et al. Among authors: inoue i. Hepatol Res. 2014 Feb;44(2):179-86. doi: 10.1111/hepr.12101. Epub 2013 Mar 27. Hepatol Res. 2014. PMID: 23531032
Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level.
Enomoto S, Tamai H, Oka M, Shingaki N, Shiraki T, Takeuchi M, Deguchi H, Magari H, Inoue I, Iguchi M, Yanaoka K, Arii K, Fujishiro M, Yahagi N, Yotsuyanagi H, Ichinose M. Enomoto S, et al. Among authors: inoue i. Hepatol Res. 2007 Sep;37(9):692-700. doi: 10.1111/j.1872-034X.2007.00112.x. Epub 2007 Jun 15. Hepatol Res. 2007. PMID: 17573949
Altered cytokine levels and increased CD4+CD57+ T cells in the peripheral blood of hepatitis C virus-related hepatocellular carcinoma patients.
Shiraki T, Takayama E, Magari H, Nakata T, Maekita T, Enomoto S, Mori Y, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Mizuno-Kamiya M, Yashiro K, Iguchi M, Tamai H, Kameyama Y, Kato J, Kondoh N, Ichinose M. Shiraki T, et al. Among authors: inoue i. Oncol Rep. 2011 Jul;26(1):201-8. doi: 10.3892/or.2011.1258. Epub 2011 Apr 12. Oncol Rep. 2011. PMID: 21491089
Relationship between vomiting reflex during esophagogastroduodenoscopy and dyspepsia symptoms.
Enomoto S, Watanabe M, Yoshida T, Mukoubayashi C, Moribata K, Muraki Y, Shingaki N, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Tamai H, Kato J, Fujishiro M, Oka M, Mohara O, Ichinose M. Enomoto S, et al. Among authors: inoue i. Dig Endosc. 2012 Sep;24(5):325-30. doi: 10.1111/j.1443-1661.2012.01241.x. Epub 2012 Mar 15. Dig Endosc. 2012. PMID: 22925284
857 results